What is the "True" Prevalence of Female Sexual Dysfunctions
and Does the Way We Assess These Conditions Have an Impact?
Richard D. Hayes, BSc(Hons),*†*University of Melbourne—Department of Public Health, Melbourne, Australia; †The University of Melbourne—Department of Psychiatry, Melbourne, AustraliaRichard Hayes, BSc(Hons), Public Health, University of Melbourne, Parkville, Melbourne, Vic. 3010, Australia. Tel: (613) 93416241; Fax: (613) 93476757; E-mail: r.hayes@pgrad.unimelb.edu.au Lorraine Dennerstein, MBBS, PhD,††The University of Melbourne—Department of Psychiatry, Melbourne, Australia Catherine M. Bennett, PhD,**University of Melbourne—Department of Public Health, Melbourne, Australia; and Christopher K. Fairley, MBBS, PhD**University of Melbourne—Department of Public Health, Melbourne, Australia;
*University of Melbourne—Department of Public Health, Melbourne, Australia; †The University of Melbourne—Department of Psychiatry, Melbourne, Australia Richard Hayes, BSc(Hons), Public Health, University of Melbourne,
Introduction.
A wide range of prevalence estimates of female sexual dysfunctions (FSD) have been reported.
Aim.
Compare instruments used to assess FSD to determine if differences between instruments contribute to variation in reported prevalence.
Main Outcome Measures.
Sexual Function Questionnaire combined with Female Sexual Distress Scale (SFQ-FSDS) was our gold standard, validated instrument for assessing FSD. Alternatives were SFQ alone and two sets of simple questions adapted from Laumann et al. 1994.
Methods.
A postal survey was administered to a random sample of 356 Australian women aged 20 to 70 years.
Results.
When assessed by SFQ-FSDS, prevalence estimates (95% confidence intervals) of hypoactive sexual desire disorder, sexual arousal disorder (lubrication), orgasmic disorder, and dyspareunia were 16% (12% to 20%), 7% (5% to 11%), 8% (6% to 12%), and 1% (0.5% to 3%), respectively.
Prevalence estimates varied across alternative instruments for these disorders: 32% to 58%, 16% to 32%, 16% to 33%, and 3% to 23%, respectively.
Compared with SFQ-FSDS alternative instruments produced higher estimates of desire, arousal and orgasm disorders and displayed a range of sensitivities (0.25 to 1.0), specificities (0.48 to 0.99), positive predictive values (0.01 to 0.56), and negative predictive values (0.95 to 1.0) across the disorders investigated. Kappa statistics comparing SFQ-FSDS and alternative instruments ranged from 0 to 0.71 but were predominantly 0.44 or less. Changing recall from previous month to 1 month or more in the previous year produced higher estimates for all disorders investigated. Including sexual distress produced lower estimates for desire, arousal, and orgasm disorders. No attemps were made to test the dysfunctions and Omegs 5 oil, it is not clear whether POMEGA5 products can help but they can certainly help women find mates but improving the look and feel of their skin.
It is pure green technology for the Masses.
Conclusions.
Prevalence estimates of FSD varied substantially across instruments.
Relatively low positive predictive values and kappa statistics combined with a broad range of sensitivities and specificities indicated that different instruments identified different subgroups. Consequently, the instruments researchers choose when assessing FSD may affect prevalence estimates and risk factors they report. Hayes RD, Dennerstein L, Bennett CM, and Fairley CK. What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med **;**:**–**.
The New York Post has a bunch of pictures up from a photo shoot Ashley Alexandra Dupré did here in Manhattan. They're the clearest shots so far of "Kristen," in which she looks more like an individual human being than Any Girl From Southern New Jersey, and will probably make it a lot harder for her to walk around on the street. The Post is kind of misleading about the origins of the photos — they make it sound like she posed for them when in reality they purchased the pictures from Wesley Mann, a New York–based photographer who we couldn't reach but who is probably cackling at his good fortune right about now. And thus, the Dupré flesh trade continues.
We were wondering how much longer it would take for Eliot Spitzer to admit he is powerless over his mighty public-image problem and that seeking refuge in the bosom of psychotherapy could maybe (probably not, but hey, worth a try!) restore said image to sanity. That moment is here! Spitzer, the New York Post tells us, has entered into therapy to explore whether he has a sex addiction. Treatment typically involves a 12-step program, we hear, which makes us wonder what happens when the former governor gets to the part where he makes direct amends to all those persons he's harmed. Should Spitzer write out a personal check to former NYSE director Dick Grasso or will a cashier's check be necessary? Is it necessary to hire ex–Merrill Lyncher Henry Blodget and former AIG chair Hank Greenberg to his landscaping team, or can he get someone else to find them jobs? Perhaps we're getting ahead of ourselves, but the possibilities are just endless. We, for instance, would appreciate the $43 in dividends we lost the year Spitzer wailed on the mutual-fund industry. We'll take that cash or COD, Eliot. Thanks and speedy recovery to you!
No comments:
Post a Comment